Successful Treatment of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Meningitis with Combination Therapy of Meropenem and Amikacin

AuthorEman Hamzaen
AuthorShahinda Rezken
AuthorHassan Eshraen
AuthorHeba Selimen
AuthorMohamed Samir Turkeyen
OrcidMohamed Samir Turkey [0000-0002-1576-0841]en
Issued Date2023-04-30en
AbstractIntroduction: The widespread use of carbapenems increased the prevalence of carbapenem-resistant Enterobacteriaceae with subsequent increases in mortality due to extremely limited treatment options. Following neurosurgical procedures, carbapenem-resistant Klebsiella pneumoniae (CRKP) is the main cause of central nervous system (CNS) infections. The optimal antimicrobial treatment of such infections has not yet been defined. Case Presentation: We present a 4-month-old boy with an extra-ventricular drain-related CNS infection with CRKP. Although meropenem minimum inhibitory concentration (MIC) for the bacterial isolate was ≥ 16 mg/L and it harbored blaNDM, blaVIM, and blaOXA-48-like carbapenemase genes, this infection was effectively treated with a combination therapy of intravenous (IV) double dose extended infusion of meropenem in addition to amikacin. Conclusions: This successful treatment regimen for CRKP-causing meningitis may pave the way to manage severe CNS infections with extensive-drug-resistant bacteria in infants and children without inserting an external drain or intra-thecal antibiotic administration.en
DOIhttps://doi.org/10.5812/apid-140658en
KeywordCarbapenem-Resistant <i>Klebsiella</i>en
KeywordIntravenousen
KeywordExtended Infusionen
KeywordMeropenemen
KeywordAmikacinen
PublisherBrieflandsen
TitleSuccessful Treatment of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Meningitis with Combination Therapy of Meropenem and Amikacinen
TypeCase Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
apid-12-1-140658.pdf
Size:
141.76 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF